References
- National Osteoporosis Foundation. Fast Facts 2006. Washington, DC: National Osteoporosis Foundation. Available at: www.nof.org/osteoporosis/diseasefacts.htm [Last accessed 11 May 2009]
- Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 2007;22:465-75
- Gupta G, Aronow WS. Treatment of postmenopausal osteoporosis [review]. Compr Ther 2007;33:114-19
- Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004;15:1003-8
- Siris E, Rosen CJ, Harris ST, et al. Adherence to bisphosphonate therapy: relationship to bone fractures at 24 months in women with postmenopausal osteoporosis. Abstract 397. Presented at the Sixth International Symposium on Osteoporosis, National Osteoporosis Foundation, Washington, DC, April 7, 2005
- Sebaldt RJ, Shane LG, Pham BZ, et al. Impact of non-compliance and non-persistence with daily bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis. Poster M423. Presented at the 26th Annual Meeting of the American Society for Bone and Mineral Research, Seattle, Washington, October 1–5, 2004
- Thier SL, Yu-Isenberg KS, Leas BF, et al. In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines. Manag Care 2008;17:48-52,55-7
- Warriner AH, Curtis JR. Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol 2009;21:356-62
- Gleeson T, Iversen MD, Avorn J, et al. Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 2009; Jun 5 [Epub ahead of print]
- Kothawala P, Badamgarav E, Ryu S, et al. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 2007;82:1493-501
- McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004;48:271-87
- Lekkerkerker F, Kanis JA, Alsayed N, et al. Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 2007;18:1311-17
- Rabenda V, Hilligsmann M, Reginster JY. Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence. Expert Opin Pharmacother 2009;10:2203-15
- Siris ES, Selby PL, Saag KG, et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 2009;122(2 Suppl.):S3-13
- Yood RA, Emani S, Reed JI, et al. Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int 2003;14:965-8
- Delmas PD, Vrijens B, Eastell R, et al. Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 2007;92:1296-304
- Eastell R, Garnero P, Vrijens B, et al. Influence of patient compliance with risedronate therapy on bone turnover marker and bone mineral density response: the IMPACT study. Calcif Tissue Int 2003;72:408. Abstract P-297
- Gold DT, Alexander IM, Ettinger MP. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy. Ann Pharmacother 2006;40:1143-50
- Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12
- Sikka, R, Xia F, Aubert RE. Estimating medication persistency using administration claims data. Am J Manag Care 2005;11:449-57
- Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74
- Miller Jr RG. Simultaneous Statistical Inference. New York: Springer-Verlag, 1991
- International Osteoporosis Foundation. The adherence gap: why osteoporosis patients don’t continue with treatment. Available at: http://www.iofbonehealth.org/publications/the-adherence-gap.html [Last accessed 16 March 2009]
- Kertes J, Dushenat M, Vesterman JL, et al. Factors contributing to compliance with osteoporosis medication. Isr Med Assoc J 2008;10:207-13
- Osterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med 2005;353:487-97